Is CRISPR Therapeutics (CRSP) Still Attractive After A 67% Five Year Share Price Decline [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
If you are trying to work out whether CRISPR Therapeutics is attractively priced or not, starting with the recent share performance and valuation checks can give you a clearer picture. The stock recently closed at US$54.65, with returns of 2.1% over 7 days, a 0.8% decline over 30 days, 1.6% year to date, 30.6% over 1 year, 9.4% over 3 years and a 67.0% decline over 5 years, which may signal that the market view on risk and potential has shifted over time. Recent attention on CRISPR Therapeutics has largely centered on its role in gene editing and the progress of its pipeline, as investors watch how new therapies and regulatory milestones play out. These developments help frame why the share price has moved the way it has and set the context for any valuation work you do next. On our simple valuation checklist, CRISPR Therapeutics scores 3 out of 6 . This suggests some areas look potentially cheap while others do not. In the sections that follow we compare different valuation ap
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- BofA is Bullish on CRISPR Therapeutics AG (CRSP) [Yahoo! Finance]Yahoo! Finance
- Assessing CRISPR Therapeutics' Valuation As Recent Trading Puts CRSP Back In Focus [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics (NASDAQ:CRSP) had its price target lowered by analysts at Bank of America Corporation from $90.00 to $89.00. They now have a "buy" rating on the stock.MarketBeat
- CRISPR Therapeutics AG (CRSP) Stock Declines While Market Improves: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Crispr Therapeutics: Patience And Opportunity Through Volatility [Seeking Alpha]Seeking Alpha
CRSP
Earnings
- 11/10/25 - Beat
CRSP
Sec Filings
- 1/27/26 - Form 4
- 1/26/26 - Form 4
- 1/22/26 - Form 4
- CRSP's page on the SEC website